Evidence map›Paper›PMID 39438022›Full record

ArticleBrain pathology (Zurich, Switzerland)2025

Nicorandil treatment improves survival and spatial learning in aged granulin knockout mice.

Dana M Niedowicz, Wang-Xia Wang, Paresh Prajapati, Yu Zhong, Shuling Fister, Colin B Rogers, Pradoldej Sompol, David K Powell, Indumati Patel, Christopher M Norris and 2 more

Abstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dana M NiedowiczSanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.ORCID 0000-0002-1052-898X
Wang-Xia WangSanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Paresh PrajapatiSanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Yu ZhongSanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Shuling FisterSanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Colin B RogersSanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Pradoldej SompolSanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
David K PowellDepartment of Neuroscience, University of Kentucky, Lexington, Kentucky, USA.
Indumati PatelSanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Christopher M NorrisSanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Kathryn E SaatmanDepartment of Physiology, University of Kentucky, Lexington, Kentucky, USA.
Peter T NelsonSanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.

Funding

Strategies for Targeting Astrocyte Reactivity in Alzheimer's Disease and Related DementiasP01AG078116 · NIA · UNIVERSITY OF KENTUCKY · PI PETER T. NELSON · 2022 to 2026
$25.0M
University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
Genetic Architecture of Pure Alzheimer's Disease and Mixed PathologyR01AG082730 · NIA · UNIVERSITY OF WASHINGTON · PI David William Fardo, Shubhabrata Mukherjee · 2023 to 2026
$4.0M
Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging (SMArT–HS)R01AG061111 · NIA · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, NELSON, PETER T. · 2019 to 2025
$3.6M
Age-related TDP-43 neuropathology: using disease-driving mechanisms to guide classificationRF1NS118584 · NINDS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CYKOWSKI, MATTHEW DANIEL, NELSON, PETER T. · 2020 to 2020
$3.2M
Novel pathogenetic mechanism for hippocampal sclerosis, a common Alzheimers mimicR01AG057187 · NIA · UNIVERSITY OF KENTUCKY · PI NELSON, PETER T. · 2017 to 2021
$2.2M
Genetic Architecture of Aging-Related TDP-43 and Mixed Pathology DementiaRF1AG082339 · NIA · UNIVERSITY OF KENTUCKY · PI FARDO, DAVID WILLIAM, NELSON, PETER T. · 2023 to 2023
$1.7M
nvestigating the role of neuroinflammation in Limbic-predominant age related TDP43 encephalopathyK08AG065463 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FLANAGAN, MARGARET E · 2020 to 2024
$816k
Aperio ScanScope XT Digital Slide Scanner SystemS10RR026489 · NCRR · UNIVERSITY OF KENTUCKY · PI NELSON, PETER T. · 2011 to 2011
$284k
NCRR NIH HHS S10 RR026489NIA NIH HHS K08 AG065463NIA NIH HHS P01 AG078116NIA NIH HHS P30 AG072946NIA NIH HHS R01 AG057187NIA NIH HHS R01 AG061111NIA NIH HHS R01 AG082730NIA NIH HHS RF1 AG082339NINDS NIH HHS P01 AG078116NINDS NIH HHS RF1 NS118584
6 · The paper itself

Abstract

Mutations in the human granulin (GRN) gene are associated with multiple diseases, including dementia disorders such as frontotemporal dementia (FTD) and limbic-predominant age-related TDP-43 encephalopathy (LATE). We studied a Grn knockout (Grn-KO) mouse model in order to evaluate a potential therapeutic strategy for these diseases using nicorandil, a commercially available agonist for the ABCC9/Abcc9-encoded regulatory subunit of the "K

Indexed as

NicorandilSpatial LearningAgingAnimalsBrainDisease Models, AnimalFemaleGranulinsMaleMaze LearningMiceMice, Inbred C57BLMice, KnockoutProgranulinsGranulinsNicorandilProgranulinsFTLD‐TDPKATPLATE‐NCprogranulinSUR2TDP‐43

Identifiers

PMID39438022
PMCPMC11961209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.